Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-blinded, Placebo-controlled Cross-over Study

NCT00853229 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00853229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00853229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-blinded, Placebo-controlled Cross-over Study
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2009
Completion date
April 30, 2013
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvar vestibulitis, vulvodynia